15 Jul 2022
According to a new study, published in The Lancet Healthy Longevity, testosterone therapy in men with hypogonadism does not increase their risk of cardiovascular complications. This is in line with existing advice from the European Medicines Agency and the UK Society for Endocrinology’s treatment guidelines.
Join the Clinical Committee as a Co-Opted Member
18 Sep 2023